TOP 10 – BIO-PHARMACEUTICAL COMPANIES

CREDIT: CHRISTOPHER FURLONG

R & D PIPELINE SIZE: 214 EMPLOYEES: 97,000 CIO: CHRIS TAYLOR

AstraZeneca is a British-Swedish pharma headquartered in Cambridge, UK, structured around oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, rare diseases and infectious diseases. The company reported US $ 58.7bn in 2025 revenue and is targeting at least 20 new medicines and US $ 80bn in annual revenue by 2030. Its oncology pipeline is among the industry’ s deepest, with more than 85 abstracts and 13 potential new medicines showcased at the 2026 American Society of Clinical Oncology annual meeting, spanning breast, liver and bladder cancers through drugs like Enhertu, Datroway and Imfinzi, plus emerging modalities such as T-cell receptor therapies and antibody-drug conjugates. With medicines sold in more than 125 countries, AstraZeneca combines breadth across cancer, chronic disease and rare conditions with a strong late-stage execution track record heading into 2026 and 2027.

TO READ MORE TOP 10s, CLICK HERE

healthcare-digital. com 49